Regeneron Pharmaceuticals REGN FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's FX effect on cash?
- Regeneron Pharmaceuticals (REGN) reported FX effect on cash of -$900K in Q1 2026.
- How has Regeneron Pharmaceuticals's FX effect on cash changed year-over-year?
- Regeneron Pharmaceuticals's FX effect on cash decreased by 250.0% year-over-year, from $600K to -$900K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.